For citations:
Bogolyubova A.V., Mayorov A.Y., Mishina E.E., Schwartz A.M., Belousov P.V. Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes. Diabetes mellitus. 2017;20(6):449-453. (In Russ.) https://doi.org/10.14341/DM9374
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
